These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 30526604)

  • 41. Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells.
    Li QQ; Xu JD; Wang WJ; Cao XX; Chen Q; Tang F; Chen ZQ; Liu XP; Xu ZD
    Clin Cancer Res; 2009 Apr; 15(8):2657-65. PubMed ID: 19336515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells.
    Lee Y; Jung WH; Koo JS
    Breast Cancer Res Treat; 2015 Sep; 153(2):323-35. PubMed ID: 26285644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cysteine cathepsins B and X promote epithelial-mesenchymal transition of tumor cells.
    Mitrović A; Pečar Fonović U; Kos J
    Eur J Cell Biol; 2017 Sep; 96(6):622-631. PubMed ID: 28495172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
    Lee HK; Lee DS; Park JC
    BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The E3 Ubiquitin Ligase HectD1 Suppresses EMT and Metastasis by Targeting the +TIP ACF7 for Degradation.
    Duhamel S; Goyette MA; Thibault MP; Filion D; Gaboury L; Côté JF
    Cell Rep; 2018 Jan; 22(4):1016-1030. PubMed ID: 29386124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
    Tsou SH; Chen TM; Hsiao HT; Chen YH
    PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LncRNA expression signatures of twist-induced epithelial-to-mesenchymal transition in MCF10A cells.
    Hu P; Yang J; Hou Y; Zhang H; Zeng Z; Zhao L; Yu T; Tang X; Tu G; Cui X; Liu M
    Cell Signal; 2014 Jan; 26(1):83-93. PubMed ID: 24113349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions between the otitis media gene, Fbxo11, and p53 in the mouse embryonic lung.
    Tateossian H; Morse S; Simon MM; Dean CH; Brown SD
    Dis Model Mech; 2015 Dec; 8(12):1531-42. PubMed ID: 26471094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
    Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
    Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
    Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. F-Box Protein 11 Suppresses Cell Proliferation and Aerobic Glycolysis in Glioblastomas by Mediating the Ubiquitin Degradation of Cdc25A.
    Liu C; Chen X; Zhang L; Liu J; Li C; Zhao J; Pu J; Tang P; Liu B; Huang X
    J Neuropathol Exp Neurol; 2022 Jun; 81(7):511-521. PubMed ID: 35582896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SSEA-1 Correlates With the Invasive Phenotype in Breast Cancer.
    Kohler KT; Møller Hansen AA; Kim J; Villadsen R
    J Histochem Cytochem; 2023 Aug; 71(8):423-430. PubMed ID: 37477396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA.
    Kasuga Y; Ouda R; Watanabe M; Sun X; Kimura M; Hatakeyama S; Kobayashi KS
    Proc Natl Acad Sci U S A; 2023 Jun; 120(24):e2218955120. PubMed ID: 37279268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultrasound-targeted microbubble destruction-mediated silencing of FBXO11 suppresses development of pancreatic cancer.
    Xue J; Chen S; Ge D; Yuan X
    Hum Cell; 2022 Jul; 35(4):1174-1191. PubMed ID: 35437704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. E3 Ubiquitin Ligases in Breast Cancer Metastasis: A Systematic Review of Pathogenic Functions and Clinical Implications.
    Wang Y; Dai J; Zeng Y; Guo J; Lan J
    Front Oncol; 2021; 11():752604. PubMed ID: 34745984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of Novel MeCP2 Cancer-Associated Target Genes and Post-Translational Modifications.
    Castro-Piedras I; Vartak D; Sharma M; Pandey S; Casas L; Molehin D; Rasha F; Fokar M; Nichols J; Almodovar S; Rahman RL; Pruitt K
    Front Oncol; 2020; 10():576362. PubMed ID: 33363010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity of CEACAM5 in breast cancer.
    Bechmann MB; Brydholm AV; Codony VL; Kim J; Villadsen R
    Oncotarget; 2020 Oct; 11(43):3886-3899. PubMed ID: 33196697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.